Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Asian J Psychiatr ; 67: 102929, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34875559

ABSTRACT

COVID-19 vaccines are one of the most effective strategies for preventing COVID-19 infection, as well as the associated mortality and morbidity. Despite the availability of COVID-19 vaccines, vaccine acceptance among perinatal women is challenging in low and middle-income countries (LMICs). Further, the vaccine hesitancy among perinatal women may have an impact on their children's vaccinations. The purpose of this paper is to briefly discuss the existing research on COVID-19 and non-COVID-19 vaccine hesitancy, psychosocial aspects, measures, and the individual level interventions for vaccine hesitancy among perinatal women. In our opinion, there is a need for further research with a specific focus on developing effective and feasible individual-level interventions to address COVID-19 vaccine hesitancy among perinatal women in LMICs.


Subject(s)
COVID-19 Vaccines , COVID-19 , Child , Developing Countries , Female , Humans , Pregnancy , SARS-CoV-2 , Vaccination Hesitancy
2.
J Assoc Physicians India ; 67(10): 26-28, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31571447

ABSTRACT

Snake bite is one of the major public health problems in India. Venom induced consumption coagulopathy(VICC) is the commonest coagulopathy resulting from viper bites. Anti-snake venom(ASV) is the only mainstay therapy in the management of snake bite. Despite anti-venom being efficacious and bonding to multiple toxins in the venom, there are number of reasons it may not be effective. The most important being irreversible toxic effects cannot be reversed by antivenom to toxin after damage has occurred, such as clotting factor deficiencies resulting from VICC. This study was done to evaluate the efficacy of use of anti-snake venom and ASV with fresh frozen plasma (FFP) in haemotoxic snake bites in a tertiary care hospital. Total 500 patients admitted during period from January 2010- April 2017 with history of snake bite. vasculotoxic[278], neurotoxic[126], localtoxic[64] and nontoxic[32]. Overall outcome in term of time recovery, renal complications, and death better in ASV plus FFP group. The complications due to snake bite were minimum, if anti snake venom was administered within first 4 hours.


Subject(s)
Disseminated Intravascular Coagulation , Snake Bites/therapy , Antivenins , Humans , India , Snake Venoms
SELECTION OF CITATIONS
SEARCH DETAIL